James Lee

James Lee has extensive work experience in the biopharmaceutical industry. James is currently working at Boundless Bio as the Sr. Director of Business Development since July 2023. Prior to that, they held the position of Director of Business Development at Boundless Bio from November 2020 to July 2023. Before joining Boundless Bio, James worked at Atomwise as the Head of Business Development in 2020 and as the Sr. Business Development Manager from 2018 to 2020. James also has experience at Genentech, where they served as the Portfolio Lead for Market Analysis & Strategy from 2016 to 2018, and as an Oncology Business Development Intern in 2015. Additionally, James worked at Accenture as a Management Consultant from 2010 to 2014, contributing to the launch of TransCelerate BioPharma. James started their career as an Associate at Synygy, evaluating sales performance and supporting integration during the Pfizer-Wyeth acquisition. James has a background in scientific research, having worked as a Research Specialist at the University of Pennsylvania School of Medicine from 2006 to 2008, focusing on esophageal cancer.

James Lee has a Master of Business Administration (MBA) degree in Healthcare and Finance from Columbia Business School. James also holds a Master of Biotechnology (MB) degree in Molecular Biotechnology and a Bachelor of Applied Science (BAS) degree in Bioengineering from the University of Pennsylvania.